鄰近類別 圖書 [1/1] 會議論文/會議摘要 [116/180] 專利 [0/4] 類別統計 近3年內發表的文件:34(10.21%) 含全文筆數:330(99.10%) 文件下載次數統計 下載大於0次:330(100.00%) 下載大於100次:317(96.06%) 檔案下載總次數:143535(77.73%) 最後更新時間: 2025-02-26 06:04 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Pan-Asian adapted ESMO clinical pra... Perspectives of the medical oncolog... Cooperative participation of CagA a... Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目51-75 / 333. (共14頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2022-04-15	The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan	American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898.
2022-04-11	Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment	Journal of Experimental and Clinical Cancer Research. 2022 Apr 11;41:Article number 137.
2022-04	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	British Journal of Cancer. 2022 Apr;126(7):1018-1026.
2022-04	Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials	Journal for Immunotherapy of Cancer. 2022 Apr;10(4):Article number e004273.
2022-02-24	Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway	International Journal of Molecular Sciences. 2022 Feb 24;23(5):Article number 2608.
2022-02-16	Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma	Cancers. 2022 Feb 16;14(4):Article number 1005.
2022-02-15	Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1	American Journal of Cancer Research. 2022 Feb 15;12(2):713-728.
2022-02	Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010)	International Journal of Urology. 2022 Feb;29(2):121-127.
2022-02	Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial	Lancet Oncology. 2022 Feb;23(2):234-247.
2022-01	Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation	Journal of the Formosan Medical Association. 2022 Jan;121(1 Pt 1):170-180.
2022-01	Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study	Gastric Cancer. 2022 Jan;25(1):207-217.
2021-11-30	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Scientific Reports. 2021 Nov 30;11:Article number 23142.
2021-11-20	Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study	Therapeutic Advances in Medical Oncology. 2021 Nov 20;Article in Press.
2021-11-12	The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience	Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
2021-10-30	Assessment of brain functional activity using a miniaturized head-mounted scanning photoacoustic imaging system in awake and freely moving rats	Biosensors. 2021 Oct 30;11(11):Article number 429.
2021-10	Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: A randomised, double-blind, multicentre, phase 2 study	Lancet Oncology. 2021 Oct;22(10):1468-1482.
2021-09-10	Stromal galectin-1 promotes colorectal cancer cancer-initiating cell features and disease dissemination through SOX9 and Beta-catenin: Development of niche-based biomarkers	Frontiers in Oncology. 2021 Sep 10;11:Article number 716055.
2021-08-03	An adjustable dark-field acoustic-resolution photoacoustic imaging system with fiber bundle-based illumination	Biosensors-Basel. 2021 Aug 3;11(8):Article number 262.
2021-07-26	Cancer registry coding via hybrid neural symbolic systems in the cross-hospital setting	IEEE Access. 2021 Jul 26;9:112081-112096.
2021-07-23	AUY922 induces retinal toxicity through attenuating TRPM1	Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
2021-07-15	How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?	Cancers. 2021 Jul 15;13(14):Article number 3536.
2021-07-15	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Scientific Reports. 2021 Jul 15;11:Article number 14567.
2021-07	Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab	Gastric Cancer. 2021 Jul;24(4):946-958.
2021-06-22	A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]	Frontiers in Oncology. 2021 Jun 22;11:Article number 718849.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.

顯示項目51-75 / 333. (共14頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目